498 related articles for article (PubMed ID: 35137496)
1. COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era.
Taga A; Lauria G
J Peripher Nerv Syst; 2022 Mar; 27(1):4-30. PubMed ID: 35137496
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.
Berrim K; Lakhoua G; Zaiem A; Charfi O; Aouinti I; Kastalli S; Daghfous R; El Aidli S
Br J Clin Pharmacol; 2023 Feb; 89(2):574-578. PubMed ID: 36398559
[TBL] [Abstract][Full Text] [Related]
3. Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports.
Abuawwad MT; Taha MJJ; Taha AJ; Kozaa YA; Falah O; Abuawwad IT; Hammad EM; Mahmoud AA; Aladawi M; Serhan HA
Clin Neurol Neurosurg; 2024 Mar; 238():108183. PubMed ID: 38401232
[TBL] [Abstract][Full Text] [Related]
4. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?
Oo WM; Giri P; de Souza A
J Neuroimmunol; 2021 Nov; 360():577719. PubMed ID: 34560365
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
Baars AE; Kuitwaard K; de Koning LC; Luijten LWG; Kok WM; Eftimov F; Wieske L; Goedee HS; van der Pol WL; Blomkwist-Markens PH; Horemans AMC; Jacobs BC; van Doorn PA
Neurology; 2023 Jan; 100(2):e182-e191. PubMed ID: 36127144
[TBL] [Abstract][Full Text] [Related]
6. Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.
Lee HY; Lien WC
Hum Vaccin Immunother; 2023 Dec; 19(1):2171231. PubMed ID: 36919452
[TBL] [Abstract][Full Text] [Related]
7. Bilateral facial palsy after COVID-19 vaccination.
Andreozzi V; D'arco B; Pagliano P; Toriello A; Barone P
Neurol Sci; 2022 Jul; 43(7):4069-4079. PubMed ID: 35364768
[TBL] [Abstract][Full Text] [Related]
8. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
[TBL] [Abstract][Full Text] [Related]
9. Chronic inflammatory demyelinating polyneuropathy after SARS-CoV2 vaccination: update of the literature and patient characterization.
Ginanneschi F; Vinciguerra C; Volpi N; Piscosquito G; Barone P; Rossi A
Immunol Res; 2023 Dec; 71(6):833-838. PubMed ID: 37395901
[TBL] [Abstract][Full Text] [Related]
10. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome in an era of global infections and 21st century vaccination.
Lunn MP
Curr Opin Neurol; 2022 Oct; 35(5):571-578. PubMed ID: 36069416
[TBL] [Abstract][Full Text] [Related]
12. Guillain-Barre syndrome following COVID-19 vaccines: A review of literature.
Yu M; Nie S; Qiao Y; Ma Y
Front Immunol; 2023; 14():1078197. PubMed ID: 36875094
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patients.
Tayebi A; Samimisedeh P; Jafari Afshar E; Mahmoudnia S; Milan N; Ayati A; Madady A; Rastad H
BMC Neurol; 2023 Dec; 23(1):437. PubMed ID: 38082244
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
[TBL] [Abstract][Full Text] [Related]
15. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination.
Suri V; Pandey S; Singh J; Jena A
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34607818
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors.
Rzymski P
Front Immunol; 2023; 14():1183258. PubMed ID: 37180147
[TBL] [Abstract][Full Text] [Related]
17. Neurological Complications Following COVID-19 Vaccination.
Chatterjee A; Chakravarty A
Curr Neurol Neurosci Rep; 2023 Jan; 23(1):1-14. PubMed ID: 36445631
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?
Introna A; Caputo F; Santoro C; Guerra T; Ucci M; Mezzapesa DM; Trojano M
Clin Neurol Neurosurg; 2021 Sep; 208():106887. PubMed ID: 34418708
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course.
de Souza A; Oo WM; Giri P
J Neurol Sci; 2022 May; 436():120231. PubMed ID: 35313224
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
